OR WAIT null SECS
February 11, 2022
EMA has started its evaluation of an application for the use of a booster dose of Comirnaty in adolescents aged 12–15 years.
EMA has started the establishment of its Data Analysis and Real World Interrogation Network (DARWIN EU) Coordination Centre.
February 10, 2022
FDA has approved sutimlimab-jome as a treatment for hemolysis in individuals with CAD.
Sartorius Stedim Biotech has completed the acquisition of the chromatography equipment division of Novasep.
The European Patent Office has granted another patent to Salipro Biotech, covering the composition-of-matter, methods, and uses of the company’s novel antigen technology.
CGT Catapult has partnered with MICA Biosystems to advance MICA’s regenerative medicine technology to the UK’s MHRA.
February 08, 2022
With new COVID-19 infections declining, the agency is resuming domestic inspections of drug manufacturing facilities.
February 07, 2022
The agency approved Roche’s Vabysmo to treat neovascular or “wet” age-related macular degeneration and diabetic macular edema.
A range of political issues have impacted FDA initiatives vital to the agency’s effectiveness and stature, both at home and on the important global stage.
February 04, 2022
ABPI has responded to the publication of a white paper on ‘Levelling Up’ by the government of the United Kingdom.